Cargando…
Parathyroid Hormone Replacement versus Oral Calcium and Active Vitamin D Supplementation in Hypoparathyroidism: A Meta-analysis
OBJECTIVES: Chronic hypoparathyroidism is treated conventionally with active vitamin D and high doses of calcium. Recombinant human parathyroid hormone (PTH) replacement is an attractive option for treating patients with hypoparathyroidism since it can replace the physiological action of native PTH....
Autores principales: | Palui, Rajan, Das, Rashmi Ranjan, Roy, Ayan, Kamalanathan, Sadishkumar, Kar, Sitanshu Sekhar, Sahoo, Jayaprakash, Selvarajan, Sandhiya, Satapathy, Amit Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333760/ https://www.ncbi.nlm.nih.gov/pubmed/32699792 http://dx.doi.org/10.4103/ijem.IJEM_579_19 |
Ejemplares similares
-
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
por: Raj, Henith, et al.
Publicado: (2019) -
The Risk of Fractures in Primary Hyperparathyroidism: A Meta‐Analysis
por: Narayanan, Niya, et al.
Publicado: (2021) -
Primary hyperparathyroidism presenting as acute pancreatitis: An institutional experience with review of the literature
por: Rashmi, K G, et al.
Publicado: (2022) -
Growth hormone and gastrointestinal malignancy: An intriguing link
por: Palui, Rajan, et al.
Publicado: (2023) -
Timing of osteoporosis therapies following fracture: the current
status
por: Palui, Rajan, et al.
Publicado: (2022)